Most studies found that germline BRCA1/2 carriers were at a higher risk of death than their BRCA-negative counterpart, but there are indications that triple-negative breast cancer patients who are BRCA1/2 carriers have a better prognosis [23, 24, 26]. Here, BRCA1 is linked to triple-negative breast carcinoma.